118 related articles for article (PubMed ID: 7095127)
21. [Effect of psychotropic drugs on the pharmacokinetics of lithium].
Samoĭlov NN; Liubimov BI; Sholokhov VM; Petrov VM
Biull Eksp Biol Med; 1980 Jun; 89(6):696-8. PubMed ID: 6104997
[TBL] [Abstract][Full Text] [Related]
22. Paradoxical effects of amitriptyline on borderline patients.
Soloff PH; George A; Nathan RS; Schulz PM; Perel JM
Am J Psychiatry; 1986 Dec; 143(12):1603-5. PubMed ID: 3538914
[TBL] [Abstract][Full Text] [Related]
23. [Personality disorder].
André C
Rev Prat; 2008 Mar; 58(5):551-6; quiz 575. PubMed ID: 18524115
[No Abstract] [Full Text] [Related]
24. [Hemodynamic effect of molsidomine in acute administration and as a long-term medication].
Osterspey A; Jansen W; Tauchert M; Schell U; Fuchs M; Hombach V; Hilger HH
Med Welt; 1983 Apr; 34(17):523-8. PubMed ID: 6408341
[No Abstract] [Full Text] [Related]
25. [Pathologic personality, temperament and treatment].
Akiskal HS
Encephale; 1995 Mar; 21 Spec No 2():47-9. PubMed ID: 7588180
[TBL] [Abstract][Full Text] [Related]
26. [Antabus is unsuitable in treatment of borderline personalities].
Aberg J
Lakartidningen; 1984 Oct; 81(41):3684-5. PubMed ID: 6503477
[No Abstract] [Full Text] [Related]
27. Borderline personality and psychotropic medication prescription in an outpatient psychiatry clinic.
Sansone RA; Rytwinski D; Gaither GA
Compr Psychiatry; 2003; 44(6):454-8. PubMed ID: 14610722
[TBL] [Abstract][Full Text] [Related]
28. Clonazepam: a novel therapeutic adjunct.
Freinhar JP; Alvarez WA
Int J Psychiatry Med; 1985-1986; 15(4):321-8. PubMed ID: 3830940
[TBL] [Abstract][Full Text] [Related]
29. [Use of the vasodilator molsidomin in the treatment of chronic cardiac insufficiency].
Mareev VIu; Sazonova LN; Grigor'iants RA; Lobova NM; Irani RM
Ter Arkh; 1983; 55(9):76-80. PubMed ID: 6688891
[No Abstract] [Full Text] [Related]
30. [Pharmacologic analysis of phenazepam and flunitrazepam activity when administered in extremely low doses].
Molodavkin GM; Burlakova EB; Cherniavskaia LI; Voronina TA; Khorseva NI; Seredenii SB
Biull Eksp Biol Med; 1996 Feb; 121(2):164-6. PubMed ID: 9026121
[No Abstract] [Full Text] [Related]
31. Psychopharmacologic management of patients with borderline personality disorder.
Links PS; Steiner M
Can J Psychiatry; 1988 Jun; 33(5):355-9. PubMed ID: 3044565
[TBL] [Abstract][Full Text] [Related]
32. [Effectiveness of combined phenazepam, thalamonal and seduxen premedication].
Darbinian TM; Papin AA; Vagina MA; Petrov OV; Zetilov VB
Anesteziol Reanimatol; 1980; (2):17-20. PubMed ID: 7386929
[No Abstract] [Full Text] [Related]
33. Pharmacotherapy of borderline personality disorder. Alprazolam, carbamazepine, trifluoperazine, and tranylcypromine.
Cowdry RW; Gardner DL
Arch Gen Psychiatry; 1988 Feb; 45(2):111-9. PubMed ID: 3276280
[TBL] [Abstract][Full Text] [Related]
34. [Pharmacotherapy of borderline disorders. A review of the literature].
Dulz B
Nervenarzt; 1994 Nov; 65(11):755-61. PubMed ID: 7816151
[TBL] [Abstract][Full Text] [Related]
35. [Pharmacological compatibility of the antineoplastic drugs ftorafur and 5-fluorouracil with the psychotropic drugs aminazine and phenazepam (an experimental study)].
Syrkin AB; Voronia TA; Mikhaĭlova LM; Suslov NI
Vestn Akad Med Nauk SSSR; 1984; (5):66-70. PubMed ID: 6429964
[No Abstract] [Full Text] [Related]
36. [Comparative effectiveness of the combined use of fenazepam, haloperidol, lithium and metabolic preparations in treating the psychopathologic disorders with obsessions in slowly progressive schizophrenia].
Kadysheva NM; Mokhovikov AN; Mosketi KV; Kryzhanovskiĭ GN
Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(10):88-92. PubMed ID: 2975124
[TBL] [Abstract][Full Text] [Related]
37. [Drug therapy of patients with emotionally unstable personality].
Nissen T
Tidsskr Nor Laegeforen; 2000 Aug; 120(18):2135-41. PubMed ID: 11006733
[TBL] [Abstract][Full Text] [Related]
38. [A new drug form of fenazepam].
Spasennikov BA; Spasennikova MG
Med Sestra; 1991 Dec; 50(12):48-51. PubMed ID: 1685552
[No Abstract] [Full Text] [Related]
39. [The pharmacokinetic aspects of the clinical action of gidazepam].
Zherdev VP; Neznamov GG; Kolyvanov GB; Litvin AA; Otabekova SG
Eksp Klin Farmakol; 1993; 56(3):50-2. PubMed ID: 8106055
[TBL] [Abstract][Full Text] [Related]
40. [Correction of psychodepressive effects of benzodiazepine tranquilizers by administration of psychostimulants].
Bobkov IuG; Morozov IS
Biull Eksp Biol Med; 1982 Oct; 94(10):48-51. PubMed ID: 6129008
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
